ANO1 and prostate carcinoma: Interestingly, cis-resveratrol demonstrated a more potent inhibition of ANO1 activity compared to trans-resveratrol, as well as a stronger effect on inhibiting cell growth and migration in PC-3 prostate cancer cells [42].